Omnicell, Inc. (OMCL)

Market Cap	1.84B
Revenue (ttm)	1.11B
Net Income (ttm)	12.53M
Shares Out	46.32M
EPS (ttm)	0.27
PE Ratio	147.11
Forward PE	22.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	419,134
Open	39.75
Previous Close	39.65
Day's Range	39.35 - 40.05
52-Week Range	25.12 - 55.75
Beta	0.78
Analysts	Buy
Price Target	52.33 (+31.75%)
Earnings Date	Feb 6, 2025

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing syst...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Aug 7, 2001
• Employees: 3,650
• Stock Exchange: NASDAQ
• Ticker Symbol: OMCL
• Website: https://www.omnicell.com

Analyst Forecast

According to 6 analysts, the average rating for OMCL stock is "Buy." The 12-month stock price forecast is $52.33, which is an increase of 31.75% from the latest price.

Price Target

$52.33

(31.75% upside)

Analyst Consensus: Buy